[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment (Q45739146)

15 December 2017

[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment (English)

1 reference

mild cognitive impairment

15 December 2017

1 reference

2

1 reference

15 December 2017

11

J O Rinne

1 reference

15 December 2017

A Brück

1

1 reference

15 December 2017

J Koivunen

3

1 reference

15 December 2017

J Koikkalainen

4

1 reference

15 December 2017

N M Scheinin

5

1 reference

15 December 2017

H Helenius

6

1 reference

15 December 2017

K Någren

7

1 reference

15 December 2017

S Helin

8

1 reference

15 December 2017

R Parkkola

9

1 reference

15 December 2017

M Viitanen

10

1 reference

15 December 2017

26 June 2013

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

15 December 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 December 2017

40

1 reference

15 December 2017

10

1 reference

15 December 2017

1567-1572

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-013-2478-8

15 December 2017

0 references

cites work

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Comparing predictors of conversion and decline in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Fast and robust multi-atlas segmentation of brain magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2478-8

Cognition, reserve, and amyloid deposition in normal aging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23801168

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-013-2478-8

1 reference

Dimensions Publication ID

15 December 2017

0 references

1 reference